NRP1
Biomarker1 paper1 finding
- Humans1
Interventions
1SGLT2 inhibitors
downin humans1Low certainty
1 study
SGLT2 inhibitors
downin humans1Low certainty
SGLT2 inhibitors decrease NRP1 in humans (74.25 vs. 87.61 ng/mL; p = 0.015).
Humanspostmenopausal women with type 2 diabetes
SGLT2 Inhibitors Are Associated With Suppression of the Sema3A/NRP1/Plexin-A1 Signaling Axis in Postmenopausal Women With Type 2 Diabetes: Evidence From Propensity Score-Matched Analysis · Journal of diabetes · 27 Aug 2026